Ernexa Therapeutics Inc. (ERNA) vs MBody AI Ltd. (MBAI)
A side-by-side comparison of Ernexa Therapeutics Inc. and MBody AI Ltd. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ERNA
Ernexa Therapeutics Inc.
$2.35HealthcareDelayed quote: Oct 6, 2026, 1:00 PM EDT
MBAI
MBody AI Ltd.
$3.20HealthcareDelayed quote: Oct 6, 2026, 12:59 PM EDT
Total return — ERNA vs MBAI
growth of $100 · dividends reinvested · last 1yERNA -94.0% (-94.0%/yr)MBAI -67.4% (-67.4%/yr)MBAI compounded faster over this window
Log scale — wide-divergence pair
ERNA MBAI
ERNA vs MBAI: by the numbers
- •ERNA is the larger company ($4M vs $3M market cap).
Metrics side by side
Valuation
| Metric | ERNA | MBAI |
|---|---|---|
| P/B ratio | 1.20 | 0.93 |
Profitability
| Metric | ERNA | MBAI |
|---|---|---|
| Gross margin | 0.00% | 0.00% |
| Operating margin | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% |
| ROE | -383.03% | 120.45% |
| ROIC | -346.94% | -69.04% |
Growth (annualized)
| Metric | ERNA | MBAI |
|---|---|---|
| Total return CAGR (5Y) | -86.83% | N/A |
Go deeper
Dig into the metrics
Ernexa Therapeutics ROEMBody AI ROEErnexa Therapeutics operating marginMBody AI operating marginErnexa Therapeutics revenue growthMBody AI revenue growthErnexa Therapeutics free cash flowMBody AI free cash flow
Ernexa Therapeutics & MBody AI appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.